Status:
COMPLETED
A Comparison of Olopatadine and Fluticasone in Patients With Allergic Conjunctivitis
Lead Sponsor:
Greiner, Jack V., OD DO PhD
Conditions:
Conjunctivitis, Allergic
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
To compare the clinical efficacy of olopatadine and fluticasone in a 3-week single center, double-masked, randomized, placebo controlled parallel treatment conjunctival allergen challenge (CAC) study ...
Detailed Description
Study will evaluate the efficacy of nasal anti-allergic therapy compared to ocular anti-allergic therapy in the prevention of ocular allergic symptoms.
Eligibility Criteria
Inclusion
- At least 18 years of age \& either sex, any race
- Willing and able to follow all instructions and attend all study visits
- Positive history of ocular allergies
- Reproducible positive ocular allergic reaction induced by conjunctival allergen challenge
Exclusion
- Have planned surgery during trial period
- Female currently pregnant, planning a pregnancy, or lactating
- Use of disallowed medications
Key Trial Info
Start Date :
February 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2008
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00655109
Start Date
February 1 2008
End Date
March 1 2008
Last Update
April 9 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ophthalmic Research Associates, Inc
North Andover, Massachusetts, United States, 01845